A Phase I Pilot Clinical Trial of TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Dose Escalation for Hypertension-Induced Intracerebral Hemorrhage Using Stereotactic Aspiration Technique to Remove the Hematoma.

Subjects

Subjects :

BLOOD coagulation factors
ZYMOGENS
TISSUE plasminogen activator
FIBRINOLYTIC agents
PROTEOLYTIC enzymes
INTRACEREBRAL hematoma
THROMBOLYTIC therapy

Details

Language :

English

ISSN :

15436772

Database :

Complementary Index

Journal :

Clinical Trials Week

Publication Type :

Periodical

Accession number :

180899520